ESSERT Robotics develops modular robot cells and MicroFactory production systems for pharmaceutical, MedTech and other high-mix manufacturing. Its platforms combine standardised hardware, process modules and lifecycle software.
About
Christopher Essert founded ESSERT GmbH in May 2012. The company moved its headquarters and expanded production in Bruchsal as it shifted from project engineering toward a reusable automation architecture. SHS Capital invested in 2023, supporting a stronger focus on pharmaceutical and life-sciences manufacturing, and ESSERT opened a North American site in Raleigh in 2026.
The MicroFactory ecosystem connects standardised robotic workstations, feeding systems and process modules through plug-and-produce interfaces. Current applications include assembly, handling, testing and inspection in regulated environments, while RoboTub targets automated nest-and-tub handling in pharmaceutical production. ESSERT’s commercial position is therefore an integrated manufacturing platform: third-party robot arms may sit inside the cells, but the company owns the system architecture, controls, validation approach and lifecycle service delivered to customers.
Comparable profiles and adjacent companies connected by shared workflow, capability, or stack position.